L Mizen

461 total citations
23 papers, 355 citations indexed

About

L Mizen is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, L Mizen has authored 23 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 8 papers in Molecular Medicine and 6 papers in Epidemiology. Recurrent topics in L Mizen's work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (8 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). L Mizen is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (8 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). L Mizen collaborates with scholars based in United Kingdom and United States. L Mizen's co-authors include R. Sutherland, Gary Woodnutt, C. Edward Dixon, P. Acred, Valerie Berry, Stephen W. Elson, James Clayton, Martin Cole, D. M. Brown and George Burton and has published in prestigious journals such as The Journal of Physiology, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

L Mizen

22 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Mizen United Kingdom 12 149 94 89 79 59 23 355
E.A.P. Croydon Australia 8 201 1.3× 34 0.4× 97 1.1× 65 0.8× 83 1.4× 12 399
Kihachiro Shimizu Japan 12 161 1.1× 147 1.6× 123 1.4× 55 0.7× 103 1.7× 41 507
M. D. DeFuria United States 7 105 0.7× 164 1.7× 57 0.6× 106 1.3× 45 0.8× 8 344
A.P. Gillett United Kingdom 10 286 1.9× 41 0.4× 109 1.2× 156 2.0× 74 1.3× 22 463
Markus Mueller Austria 9 162 1.1× 59 0.6× 98 1.1× 114 1.4× 40 0.7× 26 432
J. D. Wolny United States 8 164 1.1× 34 0.4× 103 1.2× 90 1.1× 109 1.8× 11 341
H. J. Zeiler Germany 9 170 1.1× 37 0.4× 66 0.7× 111 1.4× 23 0.4× 13 347
R. D. Foord United States 9 305 2.0× 27 0.3× 118 1.3× 142 1.8× 39 0.7× 15 493
L. Magni Sweden 10 152 1.0× 19 0.2× 72 0.8× 69 0.9× 54 0.9× 21 304
Valerie Berry United States 14 161 1.1× 105 1.1× 153 1.7× 128 1.6× 85 1.4× 20 708

Countries citing papers authored by L Mizen

Since Specialization
Citations

This map shows the geographic impact of L Mizen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Mizen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Mizen more than expected).

Fields of papers citing papers by L Mizen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Mizen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Mizen. The network helps show where L Mizen may publish in the future.

Co-authorship network of co-authors of L Mizen

This figure shows the co-authorship network connecting the top 25 collaborators of L Mizen. A scholar is included among the top collaborators of L Mizen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Mizen. L Mizen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mizen, L. (2012). Simtomax®: a new screening tool for coeliac disease. British Journal of Healthcare Management. 18(1). 27–32. 2 indexed citations
2.
Mizen, L & George Burton. (2006). The Use of Esters as Prodrugs for Oral Delivery of β-Lactam Antibiotics. Kluwer Academic Publishers eBooks. 11. 345–365. 11 indexed citations
3.
Smith, G M, et al.. (1998). Activity of Amoxicillin-Clavulanate against Penicillin-Resistant Streptococcus pneumoniae in an Experimental Respiratory Infection Model in Rats. Antimicrobial Agents and Chemotherapy. 42(4). 813–817. 12 indexed citations
4.
5.
Mizen, L, Valerie Berry, & Gary Woodnutt. (1995). The Influence of Uptake from the Gastrointestinal Tract and First-pass Effect on Oral Bioavailability of (Z)-alkyloxyimino Penicillins. Journal of Pharmacy and Pharmacology. 47(9). 725–730. 5 indexed citations
6.
Woodnutt, Gary, Valerie Berry, & L Mizen. (1995). Effect of protein binding on penetration of beta-lactams into rabbit peripheral lymph. Antimicrobial Agents and Chemotherapy. 39(12). 2678–2683. 13 indexed citations
7.
Woodnutt, Gary, Valerie Berry, & L Mizen. (1992). Simulation of human serum pharmacokinetics of cefazolin, piperacillin, and BRL 42715 in rats and efficacy against experimental intraperitoneal infections. Antimicrobial Agents and Chemotherapy. 36(7). 1427–1431. 15 indexed citations
8.
Mizen, L, et al.. (1991). Efficacy of amoxycillin/clavulanic acid in experimental Staphylococcus aureusendocarditis in the rat. Journal of Antimicrobial Chemotherapy. 27(1). 117–126. 19 indexed citations
9.
Woodnutt, Gary, et al.. (1990). Penetration of amoxycillin, ticarcillin and clavulanic add into lymph after intravenous infusion in rabbits to simulate human serum pharmacokinetics. Journal of Antimicrobial Chemotherapy. 26(5). 695–704. 2 indexed citations
10.
Mizen, L, et al.. (1989). Comparative efficacy of amoxycillin + clavulanic acid (augmentin), flucloxacillin and vancomycin against S. aureus endocarditis in the rat.. PubMed. 1(4 Suppl). 69–70. 1 indexed citations
11.
12.
Woodnutt, Gary, et al.. (1988). Temocillin efficacy in experimental Klebsiella pneumoniae meningitis after infusion into rabbit plasma to simulate antibiotic concentrations in human serum. Antimicrobial Agents and Chemotherapy. 32(11). 1705–1709. 11 indexed citations
13.
Mizen, L & Gary Woodnutt. (1988). A critique of pharmacokinetics. Journal of Antimicrobial Chemotherapy. 21(3). 273–278. 12 indexed citations
14.
Woodnutt, Gary, et al.. (1987). Pharmacokinetics and distribution of ticarcillin-clavulanic acid (Timentin) in experimental animals. Antimicrobial Agents and Chemotherapy. 31(11). 1826–1830. 6 indexed citations
15.
Dixon, C. Edward & L Mizen. (1977). Absorption of amino penicillins from everted rat intestine.. The Journal of Physiology. 269(3). 549–559. 28 indexed citations
16.
Mizen, L, et al.. (1977). Antibacterial activity of antibiotics in acrylic bone cement. Journal of Bone and Joint Surgery - British Volume. 59-B(3). 302–307. 90 indexed citations
17.
Clayton, James, et al.. (1975). Preparation, hydrolysis, and oral absorption of .alpha.-carboxy esters of carbenicillin. Journal of Medicinal Chemistry. 18(2). 172–177. 21 indexed citations
18.
Acred, P., et al.. (1970). The distribution of antibacterial agents between plasma and lymph in the dog. British Journal of Pharmacology. 39(2). 439–446. 22 indexed citations
19.
Acred, P., et al.. (1970). -amino-p-hydroxybenzylpenicillin (BRL 2333), a new broad-spectrum semisynthetic penicillin: in vivo evaluation.. PubMed. 10. 416–22. 27 indexed citations
20.
Acred, P., P. Larkin, & L Mizen. (1966). The distribution of orally administered ampicillin in calves. Veterinary Record. 79(4). 103–104. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E.A.P. Croydon Breakdown of academic impact, for papers by Kihachiro Shimizu Breakdown of academic impact, for papers by M. D. DeFuria Breakdown of academic impact, for papers by A.P. Gillett Breakdown of academic impact, for papers by Markus Mueller Breakdown of academic impact, for papers by J. D. Wolny Breakdown of academic impact, for papers by H. J. Zeiler Breakdown of academic impact, for papers by R. D. Foord Breakdown of academic impact, for papers by L. Magni Breakdown of academic impact, for papers by Valerie Berry
Rankless by CCL
2026